Structure-activity relationship study of novel anticancer aspirin-based compounds.

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Cancer Biology

Background:

• Aspirin (ASA) derivatives are being explored for enhanced therapeutic properties.
• Novel ASA-based benzyl esters (ABEs) exhibit promising anticancer effects in preliminary studies.

Purpose of the Study:

• To conduct a structure-activity relationship (SAR) study of novel ASA derivatives.
• To evaluate the anticancer activity of synthesized ABEs against human colon and pancreatic cancer cell lines.

Main Methods:

• Synthesis of a series of ASA-based benzyl esters (ABEs) with varying functional groups and leaving groups.
• In vitro evaluation of ABE inhibitory activity against HT-29, SW480, BxPC-3, and MIA PaCa-2 cancer cell lines.

Main Results:

• The nature of the salicyloyl/acyloxy group, leaving group, and benzyl ring substituents significantly influenced anticancer activity.
• Positional isomerism of substituents on the benzyl ring played a crucial role in determining inhibitory effects.
• Specific ABEs demonstrated potent inhibition of colon and pancreatic cancer cell growth.

Conclusions:

• The SAR study elucidated key structural determinants for anticancer activity in ABEs.
• The mechanism likely involves the generation of reactive intermediates like quinone methides or zwitterions.
• These novel ASA derivatives hold significant potential as anticancer agents.